Augmented Renal Clearance in Severe Infections—An Important Consideration in Vancomycin Dosing: A Narrative Review

Augmented Renal Clearance in Severe Infections—An Important Consideration in Vancomycin Dosing: A Narrative Review

Vancomycin is a hydrophilic antibiotic widely used in severe infections, including bacteremia and central nervous system (CNS) infections caused by Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), coagulase-negative staphylococci and enterococci. Appropriate antimic...

Full description

Bibliographic Details
Main Authors:	Qile Xiao, Hainan Zhang, Xiaomei Wu, Jian Qu, Lixia Qin, Chunyu Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Pharmacology
Subjects:	vancomycin critically ill infection augmented renal clearance pharmacokinetics/pharmacodynamics
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.835557/full

Similar Items

Individualized antibiotic dosage regimens for patients with augmented renal clearance
by: A-Xi Shi, et al.
Published: (2023-07-01)

Augmented Renal Clearance and How to Augment Antibiotic Dosing
by: Iris H. Chen, et al.
Published: (2020-07-01)

The influence of augmented renal clearance on vancomycin blood concentrations in patients with traumatic brain injury: Case report
by: Miljković Milijana, et al.
Published: (2022-01-01)

Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation
by: Chen LY, et al.
Published: (2024-09-01)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
by: Sixuan Zhao, et al.
Published: (2021-10-01)

Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial
by: Zahra Sahraei, et al.
Published: (2022-11-01)

Association between Augmented Renal Clearance and Inadequate Vancomycin Pharmacokinetic/Pharmacodynamic Targets in Chinese Adult Patients: A Prospective Observational Study
by: Jinjin Zhao, et al.
Published: (2022-06-01)

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
by: Idoia Bilbao-Meseguer, et al.
Published: (2022-04-01)

Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing
by: Sherif Hanafy Mahmoud, et al.
Published: (2017-09-01)

A descriptive pharmacokinetic/pharmacodynamic analysis of ceftazidime‐avibactam in a case series of critically ill patients with augmented renal clearance
by: Ying Xu, et al.
Published: (2024-02-01)

Evaluation of vancomycin individualized model-based dosing approach in neonates
by: Manal Abouelkheir, et al.
Published: (2023-05-01)

Real-Life Vancomycin Therapeutic Drug Monitoring in Coagulase-Negative Staphylococcal Bacteremia in Neonatal and Pediatric Intensive Care Unit: Are We Underestimating Augmented Renal Clearance?
by: Claudia Sette, et al.
Published: (2023-10-01)

Age-associated augmented renal clearance and low BMI trigger suboptimal vancomycin trough concentrations in children with haematologic diseases: data of 1453 paediatric patients from 2017 to 2022
by: Fengjiao Wang, et al.
Published: (2023-10-01)

Pharmacists’ Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study
by: Abdulaziz S. Almulhim, et al.
Published: (2020-06-01)

Application of Monte Carlo simulation to optimise the dosage regimen of meropenem in patients with augmented renal clearance for Pseudomonas aeruginosa infection
by: Jia Hou, et al.
Published: (2024-06-01)

Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation
by: Susan J. Lewis, et al.
Published: (2023-09-01)

Altered Pharmacokinetics Parameters of Vancomycin in Patients with Hematological Malignancy with Febrile Neutropenia, a Bayesian Software Estimation
by: Abdullah M. Alzahrani, et al.
Published: (2023-05-01)

The Development and Validation of a Simple HPLC-UV Method for the Determination of Vancomycin Concentration in Human Plasma and Application in Critically Ill Patients
by: Asma Aboelezz, et al.
Published: (2025-02-01)

Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive Bacterial Infections
by: Kai Shen, et al.
Published: (2021-04-01)

Application of machine learning combined with population pharmacokinetics to improve individual prediction of vancomycin clearance in simulated adult patients
by: Guodong Li, et al.
Published: (2024-03-01)

Clinical characteristics and early identification of augmented renal clearance in PICU patients with severe sepsis associated with MRSA infection
by: Haonan Wang, et al.
Published: (2024-11-01)

Enhanced renal clearance impacts levetiracetam concentrations in patients with traumatic brain injury with and without augmented renal clearance
by: Aaron M. Cook, et al.
Published: (2024-01-01)

Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients
by: Hsin Lin, et al.
Published: (2016-07-01)

Model-informed precision dosing in vancomycin treatment
by: Sukyong Yoon, et al.
Published: (2023-10-01)

Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function
by: Idoia Bilbao-Meseguer, et al.
Published: (2021-10-01)

What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value
by: Bruce R. Dalton
Published: (2023-02-01)

Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach
by: Qingxia Liu, et al.
Published: (2022-05-01)

Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance Phase
by: Omid Arasteh, et al.
Published: (2019-07-01)

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate
by: Jeong Eun Shin, et al.
Published: (2015-11-01)

Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit
by: Bo Zhou, et al.
Published: (2022-06-01)

Prevalence and Risk Factors of Augmented Renal Clearance: A Systematic Review and Meta-Analysis
by: Fatma Hefny, et al.
Published: (2022-02-01)

Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis
by: Zhenwei Yu, et al.
Published: (2023-12-01)

Individualized, dynamic, and full-course vancomycin dosing prediction: a study on the customized dose model
by: Xiangqing Song, et al.
Published: (2024-07-01)

Predicting Antibiotic Effect of Vancomycin Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation: Dense Sampling versus Sparse Sampling
by: Yong Kyun Kim, et al.
Published: (2022-05-01)

Sorting Out the Risks and Benefits of the #797 Recommended Intrapartum Vancomycin Dosing Approach
by: Andras Farkas, et al.
Published: (2022-12-01)

Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study
by: Wu CC, et al.
Published: (2019-08-01)

The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients
by: Yuyan Pan, et al.
Published: (2020-05-01)

Onset timing and duration of augmented renal clearance in a mixed intensive care unit
by: Ryusei Mikami, et al.
Published: (2023-03-01)

Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine
by: Matthias Gijsen, et al.
Published: (2021-09-01)

Renal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients
by: Yuqiong Wang, et al.
Published: (2024-05-01)